March 23, 2026 02:54 pm (IST)
Follow us:
Strides Arcolab signs agreement with Gilead Sciences
Bangalore/Kolkata, Jan 20 (IBNS): Strides Arcolab Limited (Strides) on Tuesday announced that it has entered into a licensing agreement with Gilead Sciences, Inc. under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs.
The license being granted to Strides extends to 112 countries, which together account for more than 30 million people living with HIV.
As part of the licensing agreement, pending U.S. Food and Drug Administration (US FDA) approval of the Gilead product, Strides will receive a technology transfer from Gilead, enabling Strides to manufacture low-cost versions of TAF for developing countries.
TAF is a novel nucleotide reverse transcriptase inhibitor that has demonstrated high antiviral efficacy at a dose 10 times lower than Gilead’s Viread (tenofovir disoproxil fumarate), as well as an improved renal and bone safety profile.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
No longer a safe haven asset? Gold, silver crash despite war as $2 trillion vanishes in hours
Mon, Mar 23 2026
India hits 1 billion tonne coal milestone—Again!
Sat, Mar 21 2026
Charge_iN by Mahindra signs strategic agreement with HPCL to develop EV charging infrastructure at HPCL retail outlets
Fri, Mar 20 2026
Bank of Baroda becomes the first bank to launch credit line on UPI - OD facility for women SHG members
Fri, Mar 20 2026
₹10 lakh cover, free services & more: TVS Motor Company rolls out big benefits with King Ka Vaada 3.0
Fri, Mar 20 2026
Rupee hits record low, breaches 93 against US dollar for first time
Fri, Mar 20 2026
Market rebounds: Sensex jumps 900 pts, Nifty gains after rout
Fri, Mar 20 2026